3 period full replicate [RSABE / ABEL]

posted by Dr_Dan  – Germany, 2015-06-24 18:43 (3515 d 16:11 ago) – Posting: # 14978
Views: 31,397

Dear Detlew

❝ The full replicate 3-period design has the sequences TRT / RTR as is stated in your post and of course has T and R replicated. Not in each subject, but if balanced in half of ntotal each. And this design of course allows the evaluation of the intra-subject variabilities of T and R separately.


I think the question is whether a replication in only half of ntotal is sufficient in order to scale or ???

❝ So what's the problem of the "leading European regulatory authority"?

❝ Especially in the light of ElMaestro's remark that only the intra-subject variability of R is of any regulatory concern if scaled ABE is aimed for :confused:.


With regard to ElMaestro's reply: in a former statement the "leading European regulatory authority" had no problem with full replicate design (=4 periods and 6 possible sequences) and half replicate designs (3 periods and 3 sequences). A full replicate 3-period design would not work according to their argumentation since a 3 period design implicity needs 3 sequences.
I do not know why. Maybe you have an idea?
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,664 registered users;
185 visitors (0 registered, 185 guests [including 5 identified bots]).
Forum time: 09:54 CET (Europe/Vienna)

Every system is perfectly designed
to get the results it gets.    Paul B. Batalden

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5